Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Ville Pettilä, Kathy Rowan et al.|Thorax|2025Cited by 12
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6